These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5929469)

  • 41. Why are typhoid vaccines not recommended for epidemic typhoid fever?
    Taylor DN; Levine MM; Kuppens L; Ivanoff B
    J Infect Dis; 1999 Dec; 180(6):2089-90. PubMed ID: 10558978
    [No Abstract]   [Full Text] [Related]  

  • 42. Household demand for typhoid fever vaccines in Hue, Vietnam.
    Do GC; Whittington D; Le TK; Utomo N; Nguyen TH; Poulos C; Dang TD; Kim D; Nyamete A; Acosta C
    Health Policy Plan; 2006 May; 21(3):241-55. PubMed ID: 16581824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Chloromycetin in the treatment of a Salmonella typhi carrier].
    KVADSHEIM H
    Nord Med; 1951 Feb; 45(7):240. PubMed ID: 14827257
    [No Abstract]   [Full Text] [Related]  

  • 44. [Salmonella typhi--time to change empiric treatment].
    Gade C; Engberg J; Weis N
    Ugeskr Laeger; 2008 Sep; 170(40):3133-4. PubMed ID: 18823602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Observations on chloramphenicol resistance induced in vitro in a typhoid strain].
    CORDA M
    Boll Soc Ital Biol Sper; 1950; 26(5):798-800. PubMed ID: 14801205
    [No Abstract]   [Full Text] [Related]  

  • 46. [Typhoid fever epidemic in the Ivory Coast in vaccinated French military personnel].
    Michel R; Garnotel E; Spiegel A; Todesco A; Ollivier-Gay L; Galoisy-Guibal L; Morillon M; Boutin JP; Baudon D
    Med Trop (Mars); 2001; 61(6):549-50. PubMed ID: 11980408
    [No Abstract]   [Full Text] [Related]  

  • 47. [Considerations on the value of some laboratory tests for the evaluation of the effectiveness of the TAB vaccine].
    Chiresco N; Rímniceanu I
    Arch Roum Pathol Exp Microbiol; 1964 Mar; 23(1):261-6. PubMed ID: 4961118
    [No Abstract]   [Full Text] [Related]  

  • 48. [Immunologic basis for typhoid carrier state formation and methods of prevention].
    Bunin KV
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Sep; 47(9):5-10. PubMed ID: 5519106
    [No Abstract]   [Full Text] [Related]  

  • 49. [General immunity reactions in man after oral administration of a typhoid fever entero-vaccine].
    Karolcek J; Rusinko M; Draskovicová M; Mikulková M; Báteerová L; Luzová D
    Zentralbl Bakteriol Orig; 1965 Aug; 197(2):224-34. PubMed ID: 5860332
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
    Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Contributions to the problem of typhoid bacillus long-term carriers with special reference to typhoid patients treated with chloramphenicol].
    MUENNICH D
    Z Gesamte Inn Med; 1962 May; 17():424-31. PubMed ID: 14476973
    [No Abstract]   [Full Text] [Related]  

  • 52. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Observations on chloramphenicol resistance induced in vitro in a typhoid strain. III. Metabolic comparison between the resistant strain and the original (sensitive)].
    CORDA M
    Boll Soc Ital Biol Sper; 1950; 26(5):803-5. PubMed ID: 14801207
    [No Abstract]   [Full Text] [Related]  

  • 54. [A case of meningitis due to Salmonella typhi treated with aureomycin and chloromycetin].
    DANIEL MARTINEZ P; GOMEZ OROZCO L; PEREZ NAVARRETE JL
    Bol Med Hosp Infant Mex; 1951 Oct; 7(5):701-6. PubMed ID: 14848158
    [No Abstract]   [Full Text] [Related]  

  • 55. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
    Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
    J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two types of immunity in experimental typhoid; "cellular immunity" and "humoral immunity".
    Ushiba D
    Keio J Med; 1965 Jun; 14(2):45-61. PubMed ID: 5827250
    [No Abstract]   [Full Text] [Related]  

  • 57. [Action of synthetic chloramphenicol on the typhoid bacillus Eberthella typhosa studied by the phase contrast microscope].
    LEVADITI C; VAISMAN A; HENRY-EVENO J
    Presse Med (1893); 1950 Jun; 58(38):665-6. PubMed ID: 15430269
    [No Abstract]   [Full Text] [Related]  

  • 58. A single shot at Salmonella typhi: a new typhoid vaccine with pediatric advantages.
    Hall CB
    Pediatrics; 1995 Aug; 96(2 Pt 1):348-50. PubMed ID: 7630698
    [No Abstract]   [Full Text] [Related]  

  • 59. [A new hemagglutination reaction in the serum of typhoid patients by means of the human erythrocytes coated by the culture filtrate of typhoid bacilli].
    NAKAMURA S
    Jpn J Med Sci Biol; 1961 May; 50():135-41. PubMed ID: 13727625
    [No Abstract]   [Full Text] [Related]  

  • 60. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India.
    Gupta V; Kaur J; Kaistha N
    Trop Doct; 2009 Jan; 39(1):28-30. PubMed ID: 19211419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.